Susquehanna Fundamental Investments’s 2seventy bio TSVT Stock Holding History

Susquehanna Fundamental Investments’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-68,425	Closed	-$338K	–	1006
2025 Q1	$338K	Sell	68,425 -25,055	-27%	-$79.6K	﹤0.01%	934
2024 Q4	$275K	Buy	+93,480	New	+$383K	﹤0.01%	959
2024 Q2	$740K	Buy	192,319 +54,076	+39%	+$244K	0.02%	611
2024 Q1	$740K	Buy	+138,243	New	+$650K	0.03%	401
2023 Q4	–	Sell	-42,946	Closed	-$168K	–	318
2023 Q3	$168K	Sell	42,946 -6,392	-13%	-$41.9K	0.01%	333
2023 Q2	$499K	Sell	49,338 -18,155	-27%	-$192K	0.02%	442
2023 Q1	$688K	Hold	67,493	–	–	0.02%	607
2022 Q4	$632K	Buy	+67,493	New	+$952K	0.01%	792

Other funds holding TSVT

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna Fundamental Investments's TSVT Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 68,425 shares — an estimated $338K sold.

Susquehanna Fundamental Investments first reported a position in TSVT in Q4 2022 and held it in 8 quarters. The position peaked at $740K in Q2 2024. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Susquehanna Fundamental Investments reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 68,425 2seventy bio shares in Q2 2025, an estimated $338K.
Susquehanna Fundamental Investments first reported a position in 2seventy bio in Q4 2022 and held it in 8 quarters.
Susquehanna Fundamental Investments's 2seventy bio position peaked at $740K in Q2 2024.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.